Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2007

Open Access 01.12.2007 | Case report

Primary presacral neuroendocrine tumor associated with imperforate anus

verfasst von: Tad Kim, Stephen R Grobmyer, Chen Liu, Steven N Hochwald

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Presacral masses are unusual growths that have a limited differential diagnosis, typically not including neuroendocrine tumors (NETs). Classically, NETs are well-differentiated gastroenteropancreatic tumors of probable benign behavior. These tumors are associated with a typical morphologic pattern and involve the distal colon, rectum, and genitourinary tract; they are considered less aggressive, frequently asymptomatic, and rarely cause carcinoid syndrome, even when metastatic. Neuroendocrine tumors of the presacral region are extremely rare and few have been described in the literature. They have not been previously reported as being associated with imperforate anus.

Case presentation

We present an interesting case of a woman with a history of imperforate anus that was found to have a primary neuroendocrine tumor of the presacral region with no rectal wall involvement.

Conclusion

We argue that this is a primary gastroenteropancreatic neuroendocrine tumor which likely originated from cells of hindgut origin that underwent an abnormal migration during embryonic development.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-5-115) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

TK- Participated in the design of the study and helped to draft the manuscript. SRG- Conceived of the study and participated in its design and coordination and help to draft the manuscript. SNH- conceived of the study, participated in its design and coordination and helped to draft the manuscript, performed the revisions. All authors read and approved the final version of the manuscript.

Background

Neuroendocrine tumors are rare with an incidence rate of two to five per 100,000, with a higher incidence rate for African-American men and women. The age distribution ranges from the second to the ninth decade, with peak incidence between the ages of 50 and 70. They are the most common neuroendocrine tumor of the gastrointestinal tract. Around 55% are located in the gastrointestinal tract and 30% in the bronchopulmonary system. In the gastrointestinal tract, they tend to arise most commonly in the small intestine (45%), followed by rectum (20%), appendix (16%), colon (11%), and stomach (7%) [1].
Neuroendocrine tumors of the presacral region are rare and usually represent direct extension or metastasis from primary rectal tumors. Only a handful of primary presacral NETs have been reported in the literature and are felt presumably to derive from hindgut rests, especially given their histopathologic similarity with primary rectal NETs [2]. We report a rare case of a primary presacral NET in a patient with a history of imperforate anus, which is associated with abnormalities in hindgut cell migration and explains the predisposition to develop a classic hindgut-like gastroenteropancreatic NET in this region.

Case presentation

A 58 year old African-American female reported symptoms of abdominal pain and diarrhea. Physical examination including abdominal, vaginal, cervical and rectal exam were not contributory. She was found on computerized tomography scan of the abdomen/pelvis to have a 3.2 cm heterogeneous mass anterior to the coccyx, with central hypodensity and peripheral rim enhancement; the mass appeared separate from the posterior rectal wall. The pelvic organs were unremarkable, as no other abnormalities were identified on CT scan. Subsequent CT-guided biopsy and pathology was consistent with a neuroendocrine tumor. Colonoscopy was negative for primary tumor of the rectum. Transanal endoscopic ultrasound confirmed a heterogeneous and hypoechoic mass at 13 cm from the anal verge, clearly separate from the posterior rectal wall, with no discernible lymphadenopathy (Figure 1). The posterior vaginal wall was visualized and unremarkable. Somatostatin receptor scintigraphy scan (SSRS) revealed uptake in the presacral mass compatible with neuroendocrine tumor, but no other sites of disease.
The patient had a history of imperforate anus, having lived with a colostomy up until ten years of age. At that time she underwent two coloanal pull through procedures through both an abdominal and transsacral approach with creation of a neoanus (Figure 2). Prior to our evaluation, her bowel function was described as having fecal continence with occasional loose stools and irregular bowel movements. Of note, she did not have any wheezing, flushing, pellagra, or other symptomatology to meet a constellation typical of the "carcinoid syndrome". Her abdominal pain resolved prior to any treatment for her presacral mass and was felt not related to her NET. Therefore, her NET was considered an incidental finding.
At operation, she underwent transsacral resection of the NET with partial removal of the sacrum and removal of the entire coccyx and mass (Figures 3, 4 and 5). The surgery was complicated by the presence of scar tissue from previous coloanal pull through procedures. A vertical incision over the sacrum and coccyx was performed. The subcutaneous tissue was divided down to the sacral bone. The tumor appeared to extend in the presacral plane up to about the S4-5 level. Thus, the sacral bone was divided at the S4 level and then the presacral area was entered and dissection continued in this plane. Notably, the tumor was slightly adherent to perirectal fat, but not invading or emanating from the rectal wall. The tumor was dissected away without difficulty from the posterior rectal wall and neoanus.
Postoperatively, the patient did well and was discharged without complications. She had no new symptoms of incontinence, rectal, or back pain. Her bowel habits and loose stools remained at her pre-operative baseline. There was no evidence of recurrence of disease after 10 months of follow up.

Pathology

The specimen consisted of a tumor mass with surrounding fibrous tissue. There was no evidence of lymphatic tissue in the specimen. Permanent sections revealed cytologically bland and monotonous cells arranged in cords or ribbons. Nuclei were round to oval, small, and occasionally featuring nucleoli. Mitotic rate was low, no necrosis or angioinvasion were noted. Characteristic "salt-and-pepper" neurosecretory granules were seen. Immunohistochemistry showed positivity for synaptophysin, neuron specific enolase, chromogranin and cytokeratin. The tumor was negative for S-100 (Figure 6). A paraganglioma was ruled out since the cells did not exhibit a nesting cell growth pattern. The cells were not large and did not have abundant cytoplasm. Intracytoplasmic globules were not present. The cells were positive for cytokeratin, while paragangliomas are usually negative. Most characteristically, S-100 staining is positive and highlights the sustentacular cells between the solid-sheets of a paraganglioma. The resected tumor was negative for S-100.
All of these features confirmed this tumor to be a well differentiated neuroendocrine tumor according to the WHO classification.

Discussion

The presacral space is a region bounded by the rectum anteriorly, sacrum posteriorly, peritoneal reflection superiorly and perineal muscles inferiorly. The differential diagnosis of lesions arising in this area include solid tumors such as teratomas, chordomas, paragangliomas and ependymomas, or cystic lesions, such as tailgut cysts, duplication cysts, and dermoid cysts, thought to arise from the embryological tailgut or neurenteric canal. An association between tailgut cysts and presacral NETs is described in the literature. Furthermore, NETs of the presacral space are histopathologically similar to rectal NETs. The theory is that the presence of remnant hindgut cells may be the basis for development of neuroendocrine tumors in this region.
A review of the literature revealed 15 prior cases of primary presacral NET [214] (Table 1). There may be a female preponderance with these rare tumors as two-thirds of the cases have been seen in women. Seven previously reported cases were associated with tailgut cysts and two were associated with sacrococcygeal teratomas. Interestingly, we report the first case in the literature of this tumor arising in a patient who had a history of imperforate anus.
Table 1
Previous case reports describing the presence of a presacral carcinoid
Case number
Author(reference)
Age/sex
Associated anomaly
1
[3]
61/Male
Sacrococcygeal teratoma
2
[4]
35/Female
Presacral teratoma
3
[5]
18/Female
Tailgut cyst
4
[6]
61/Male
None
5
[7]
NA/Female
None
6
[2]
19/Female
Tailgut cyst
7
[2]
19/Female
None
8
[2]
21/Female
None
9
[8]
42/Female
None
10
[9]
69/Female
Tailgut cyst
11
[10]
52/Male
Tailgut cyst
12
[11]
68/Male
Tailgut cyst
13
[12]
41/Female
Tailgut cyst
14
[13]
NA/NA
Tailgut cyst
15
[14]
37/Male
Sacrococcygeal teratomas
16
This report
58/Female
Imperforate anus
Incomplete migration and/or fusion of the urorectal septum with the cloacal membrane lead to persistence of the cloaca and/or fistulae. Imperforate anus results from persistence of the dorsal cloacal membrane [15, 16] and ventral persistence causes absent urethral and vaginal openings. There appears to be a 'malfunctioning of cells ingressing from an end-stage primitive streak' that leads to defective development of the dorsal cloaca [17]. Our postulate is that incomplete or impaired migration of hindgut cells led to both our patient's imperforate anus, and the predisposition to develop a primary neuroendocrine tumor from persistent hindgut rests in the presacral region. In fact, there was no evidence suggesting that the tumor emanated from the rectal wall. Colonoscopy failed to show a primary rectal tumor. EUS and CT images clearly demonstrate the tumor location outside the rectal wall. At surgery, the tumor was found to not involve the rectal wall. A somatostatin receptor scintography scan ruled out the chance that this tumor was metastatic from elsewhere as primary uptake was found in the presacral mass with no uptake in other sites. While carcinoid tumors can arise from other pelvic organs, besides the rectum, there was no evidence of primary tumors in the vagina, cervix or ovaries.
Our patient presented initially with abdominal pain and diarrhea, and was found to have an incidental presacral mass on CT scan. It was determined that her presenting symptoms were not related to the presence of this tumor but to a brief episode of nonspecific colitis. The neuroendocrine tumor was diagnosed after an appropriate diagnostic work-up following the most current guidelines [18, 19]. Classically, gastroenteropancreatic neuroendocrine tumors are indolent and do not manifest symptoms unless they are either secretory tumors or are locally advanced to cause obstructive symptoms or have metastasized. The carcinoid syndrome, characterized by such symptoms as flushing, diarrhea, and wheezing, usually results from liver metastasis and subsequent release of vasoactive compounds such as serotonin [18]. The somatostatin receptor scintigraphy scan demonstrated no metastasis, nor did our patient exhibit a constellation of symptoms to suggest an actual carcinoid syndrome. Furthermore, she did not present with obstructive-type symptoms secondary to the mass. The histopathologic findings were of a well-delineated mass composed of highly differentiated neuroendocrine cells, displaying no angioinvasion and with a low mitotic index. The tumor cells were positive for chromogranin, synaptophysin, cytokeratin and negative for S-100. A paraganglioma was ruled out based on these findings and the lack of the typical histologic appearance. Our patient's clinical picture and above histopathologic findings are all consistent with the standard World Health Organization (WHO) classification of a well-differentiated gastroenteropancreatic neuroendocrine tumor of probable benign behavior [18, 20, 21].
In conclusion, we report the first case of primary presacral neuroendocrine tumor, of likely gastroenteropancreatic and, more specifically, originating from abnormal migration of hindgut cells in a patient with imperforate anus. There was no tumor involvement of the rectal wall on preop EUS or CT imaging or during surgical resection. The presence of previous surgery in the pelvis to create a neoanus resulted in increased complexity when determining the treatment options for this patient. However, as demonstrated by this case for tumors below the S3 level, despite previous surgery in the low pelvis, a transsacral approach for resection should be feasible, with careful preservation of the rectal wall [8].

Acknowledgements

Written informed consent was obtained from the patient for publication of this case report.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

TK- Participated in the design of the study and helped to draft the manuscript. SRG- Conceived of the study and participated in its design and coordination and help to draft the manuscript. SNH- conceived of the study, participated in its design and coordination and helped to draft the manuscript, performed the revisions. All authors read and approved the final version of the manuscript.
Literatur
1.
Zurück zum Zitat Sippel RS, Chen H: Carcinoid tumors. Surg Oncol Clin N Am. 2006, 15: 463-478. 10.1016/j.soc.2006.05.002.CrossRefPubMed Sippel RS, Chen H: Carcinoid tumors. Surg Oncol Clin N Am. 2006, 15: 463-478. 10.1016/j.soc.2006.05.002.CrossRefPubMed
2.
Zurück zum Zitat Horenstein MG, Erlandson RA, Gonzalez-Cueto DM, Rosai J: Presacral carcinoid tumors: report of three cases and review of the literature. Am J Surg Pathol. 1998, 22: 251-255. 10.1097/00000478-199802000-00015.CrossRefPubMed Horenstein MG, Erlandson RA, Gonzalez-Cueto DM, Rosai J: Presacral carcinoid tumors: report of three cases and review of the literature. Am J Surg Pathol. 1998, 22: 251-255. 10.1097/00000478-199802000-00015.CrossRefPubMed
3.
Zurück zum Zitat Aparicio SR, Cowen PN, Croft CB: Argentaffin carcinoma arising in a sacrococcygeal teratoma. J Pathol. 1972, 107: 49-53. 10.1002/path.1711070109.CrossRefPubMed Aparicio SR, Cowen PN, Croft CB: Argentaffin carcinoma arising in a sacrococcygeal teratoma. J Pathol. 1972, 107: 49-53. 10.1002/path.1711070109.CrossRefPubMed
4.
Zurück zum Zitat Fiandaca MS, Ross WK, Pearl GS, Bakay RA: Carcinoid tumor in a presacral teratoma associated with an anterior sacral meningocele: case report and review of the literature. Neurosurgery. 1988, 22: 581-588. 10.1097/00006123-198803000-00025.CrossRefPubMed Fiandaca MS, Ross WK, Pearl GS, Bakay RA: Carcinoid tumor in a presacral teratoma associated with an anterior sacral meningocele: case report and review of the literature. Neurosurgery. 1988, 22: 581-588. 10.1097/00006123-198803000-00025.CrossRefPubMed
5.
Zurück zum Zitat Lin SL, Yang AH, Liu HC: Tailgut cyst with carcinoid: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1992, 49: 57-60. Lin SL, Yang AH, Liu HC: Tailgut cyst with carcinoid: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1992, 49: 57-60.
6.
Zurück zum Zitat Schnee CL, Hurst RW, Curtis MT, Friedman ED: Carcinoid tumor of the sacrum: case report. Neurosurgery. 1994, 35: 1163-1167. 10.1097/00006123-199412000-00024.CrossRefPubMed Schnee CL, Hurst RW, Curtis MT, Friedman ED: Carcinoid tumor of the sacrum: case report. Neurosurgery. 1994, 35: 1163-1167. 10.1097/00006123-199412000-00024.CrossRefPubMed
7.
Zurück zum Zitat Edelstein PS, Wong WD, La VJ, Rothenberger DA: Carcinoid tumor: an extremely unusual presacral lesion. Report of a case. Dis Colon Rectum. 1996, 39: 938-942. 10.1007/BF02053995.CrossRefPubMed Edelstein PS, Wong WD, La VJ, Rothenberger DA: Carcinoid tumor: an extremely unusual presacral lesion. Report of a case. Dis Colon Rectum. 1996, 39: 938-942. 10.1007/BF02053995.CrossRefPubMed
8.
Zurück zum Zitat Gorski T, Khubchandani IT, Stasik JJ, Riether R: Retrorectal carcinoid tumor. South Med J. 1999, 92: 417-420.CrossRefPubMed Gorski T, Khubchandani IT, Stasik JJ, Riether R: Retrorectal carcinoid tumor. South Med J. 1999, 92: 417-420.CrossRefPubMed
9.
Zurück zum Zitat Prasad AR, Amin MB, Randolph TL, Lee CS, Ma CK: Retrorectal cystic hamartoma: report of 5 cases with malignancy arising in 2. Arch Pathol Lab Med. 2000, 124: 725-729.PubMed Prasad AR, Amin MB, Randolph TL, Lee CS, Ma CK: Retrorectal cystic hamartoma: report of 5 cases with malignancy arising in 2. Arch Pathol Lab Med. 2000, 124: 725-729.PubMed
10.
Zurück zum Zitat Oyama K, Embi C, Rader AE: Aspiration cytology and core biopsy of a carcinoid tumor arising in a retrorectal cyst: a case report. Diagn Cytopathol. 2000, 22: 376-378. 10.1002/(SICI)1097-0339(200006)22:6<376::AID-DC9>3.0.CO;2-6.CrossRefPubMed Oyama K, Embi C, Rader AE: Aspiration cytology and core biopsy of a carcinoid tumor arising in a retrorectal cyst: a case report. Diagn Cytopathol. 2000, 22: 376-378. 10.1002/(SICI)1097-0339(200006)22:6<376::AID-DC9>3.0.CO;2-6.CrossRefPubMed
11.
Zurück zum Zitat Mourra N, Caplin S, Parc R, Flejou JF: Presacral neuroendocrine carcinoma developed in a tailgut cyst: report of a case. Dis Colon Rectum. 2003, 46: 411-413. 10.1007/s10350-004-6564-7.CrossRefPubMed Mourra N, Caplin S, Parc R, Flejou JF: Presacral neuroendocrine carcinoma developed in a tailgut cyst: report of a case. Dis Colon Rectum. 2003, 46: 411-413. 10.1007/s10350-004-6564-7.CrossRefPubMed
12.
Zurück zum Zitat Song DE, Park JK, Hur B, Ro JY: Carcinoid tumor arising in a tailgut cyst of the anorectal junction with distant metastasis: a case report and review of the literature. Arch Pathol Lab Med. 2004, 128: 578-580.PubMed Song DE, Park JK, Hur B, Ro JY: Carcinoid tumor arising in a tailgut cyst of the anorectal junction with distant metastasis: a case report and review of the literature. Arch Pathol Lab Med. 2004, 128: 578-580.PubMed
13.
Zurück zum Zitat Jacob S, Dewan Y, Joseph S: Presacral carcinoid tumour arising in a tailgut cyst--a case report. Indian J Pathol Microbiol. 2004, 47: 32-33.PubMed Jacob S, Dewan Y, Joseph S: Presacral carcinoid tumour arising in a tailgut cyst--a case report. Indian J Pathol Microbiol. 2004, 47: 32-33.PubMed
14.
Zurück zum Zitat Luong TV, Salvagni S, Bordi C: Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case. Dig Liver Dis. 2005, 37: 278-281. 10.1016/j.dld.2004.10.014.CrossRefPubMed Luong TV, Salvagni S, Bordi C: Presacral carcinoid tumour. Review of the literature and report of a clinically malignant case. Dig Liver Dis. 2005, 37: 278-281. 10.1016/j.dld.2004.10.014.CrossRefPubMed
15.
Zurück zum Zitat Catala M: Genetic control of caudal development. Clin Genet. 2002, 61: 89-96. 10.1034/j.1399-0004.2002.610202.x.CrossRefPubMed Catala M: Genetic control of caudal development. Clin Genet. 2002, 61: 89-96. 10.1034/j.1399-0004.2002.610202.x.CrossRefPubMed
16.
Zurück zum Zitat Kimmel SG, Mo R, Hui CC, Kim PC: New mouse models of congenital anorectal malformations. J Pediatr Surg. 2000, 35: 227-230. 10.1016/S0022-3468(00)90014-9.CrossRefPubMed Kimmel SG, Mo R, Hui CC, Kim PC: New mouse models of congenital anorectal malformations. J Pediatr Surg. 2000, 35: 227-230. 10.1016/S0022-3468(00)90014-9.CrossRefPubMed
17.
Zurück zum Zitat van der Putte SC: Anal and ano-urogenital malformations: a histopathological study of "imperforate anus" with a reconstruction of the pathogenesis. Pediatr Dev Pathol. 2006, 9: 280-296. 10.2350/06-01-0034.1.CrossRefPubMed van der Putte SC: Anal and ano-urogenital malformations: a histopathological study of "imperforate anus" with a reconstruction of the pathogenesis. Pediatr Dev Pathol. 2006, 9: 280-296. 10.2350/06-01-0034.1.CrossRefPubMed
18.
Zurück zum Zitat Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A, UKNETwork for Neuroendocrine Tumours: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005, 54 (Suppl 4): iv-16. 10.1136/gut.2004.053314. Ramage JK, Davies AH, Ardill J, Bax N, Caplin M, Grossman A, Hawkins R, McNicol AM, Reed N, Sutton R, Thakker R, Aylwin S, Breen D, Britton K, Buchanan K, Corrie P, Gillams A, Lewington V, McCance D, Meeran K, Watkinson A, UKNETwork for Neuroendocrine Tumours: Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut. 2005, 54 (Suppl 4): iv-16. 10.1136/gut.2004.053314.
19.
Zurück zum Zitat Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M, Nordic NE Tumour Group: Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol. 2004, 43 (7): 617-625. 10.1080/02841860410018575.CrossRefPubMed Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M, Nordic NE Tumour Group: Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol. 2004, 43 (7): 617-625. 10.1080/02841860410018575.CrossRefPubMed
20.
Zurück zum Zitat Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Valimaki M: Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Acta Oncol. 2004, 43: 626-636. 10.1080/02841860410018584.CrossRefPubMed Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Valimaki M: Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Acta Oncol. 2004, 43: 626-636. 10.1080/02841860410018584.CrossRefPubMed
21.
Zurück zum Zitat Rindi G, Capella C, Solcia E: Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med. 2000, 44: 13-21.PubMed Rindi G, Capella C, Solcia E: Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract. Q J Nucl Med. 2000, 44: 13-21.PubMed
Metadaten
Titel
Primary presacral neuroendocrine tumor associated with imperforate anus
verfasst von
Tad Kim
Stephen R Grobmyer
Chen Liu
Steven N Hochwald
Publikationsdatum
01.12.2007
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2007
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-5-115

Weitere Artikel der Ausgabe 1/2007

World Journal of Surgical Oncology 1/2007 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.